Altered signaling in anti-estrogen-resistant human breast cancer cells

Ítems similars

• Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation
  per: Larsen, SS, et al.
  Publicat: (2000)
• Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
  per: Løkkegaard, S, et al.
  Publicat: (2011)
• The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
  per: Martin, L-A, et al.
  Publicat: (2005)
• Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells
  per: Chewchuk, Simon, et al.
  Publicat: (2017)
• Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways
  per: Lundholt, BK, et al.
  Publicat: (2000)